Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hydroxyzine × Myeloid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1 Gynecologic 1

Conditions

Myeloproliferative Disorders 1

Interventions

Cyclophosphamide 232 fludarabine phosphate 206 Azacitidine 164 fludarabine 160 Busulfan 148 Cytarabine 136 Imatinib Mesylate 132 Mycophenolic Acid 128 Whole-Body Irradiation 123 Tacrolimus 118 Peripheral Blood Stem Cell Transplantation 117 Cyclosporine 98 Melphalan 97 Antilymphocyte Serum 95 Decitabine 90 Filgrastim 89 Methotrexate 87 nilotinib 75 venetoclax 67 ruxolitinib 64 Granulocyte Colony-Stimulating Factor 56 Stem Cell Transplantation 55 Radiotherapy 54 Dasatinib 54 Thiotepa 52 thymoglobulin 51 Etoposide 44 Specimen Handling 42 Clofarabine 39 Cord Blood Stem Cell Transplantation 38

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03808805 2025-12-03

APHYPAP

University Hospital, Brest

Phase 3 Completed

Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡